Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Inventory (2021 - 2025)

Pulse Biosciences has reported Inventory over the past 3 years, most recently at $57000.0 for Q3 2025.

  • Quarterly results put Inventory at $57000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $57000.0 (changed N/A YoY), and the annual figure for FY2021 was $5.8 million, changed.
  • Inventory for Q3 2025 was $57000.0 at Pulse Biosciences, up from $51000.0 in the prior quarter.
  • Over the last five years, Inventory for PLSE hit a ceiling of $7.9 million in Q2 2022 and a floor of $30000.0 in Q1 2025.
  • Median Inventory over the past 3 years was $1.9 million (2021), compared with a mean of $3.0 million.
  • Peak annual rise in Inventory hit 559.65% in 2022, while the deepest fall reached 82.48% in 2022.
  • Pulse Biosciences' Inventory stood at $5.8 million in 2021, then crashed by 87.12% to $750000.0 in 2022, then tumbled by 92.4% to $57000.0 in 2025.
  • The last three reported values for Inventory were $57000.0 (Q3 2025), $51000.0 (Q2 2025), and $30000.0 (Q1 2025) per Business Quant data.